Pronethalol
Pronethalol, sold under the brand name Alderlin, was an early non-selective beta blocker.
≈ 1 min read
Pronethalol. encyclopegia.org, snapshot enwiki-001366469266. /a/pronethalol
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Pronethalol, sold under the brand name Alderlin, was an early non-selective beta blocker. It was the first beta blocker to be developed by James Black and associates at Imperial Chemical Industries, and the first to enter clinical use, in November 1963.
However, it was never used widely due to carcinogenicity in mice, which was thought to result from formation of a carcinogenic naphthalene epoxide metabolite, and was superseded by propranolol from 1965 onward.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1366469266 under CC BY-SA 4.0; modifications have been made.